Depressive Disorder, Major: all 2,805 studies
Page 20 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.
- Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.CompletedNCT03435744Phase 3
- Switching From SSRI to Desvenlafaxine on Cognitive FunctioningStatus unknownNCT03432221
- Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)CompletedNCT03430869Phase 2
- Testing the Value of Smartphone Assessments of People With Mood DisordersCompletedNCT03429361
- Neurofeedback for Treatment Resistant DepressionCompletedNCT03428828Not applicable
- Trial of MR-guided Focused Ultrasound for Treatment of Refractory Major DepressionCompletedNCT03421574Not applicable
- NMDA Modulation in Major Depressive Disorder in Late- LifeCompletedNCT03414931Phase 2
- The Role of Cognitive Control in the Transdiagnostic Conceptualization of "Intrusive Thoughts"CompletedNCT03414619Not applicable
- Smartphone-enabled Health Coaching Intervention for Youth Diagnosed With Major Depressive DisordersSuspendedNCT03406052Not applicable
- Sleep, Wake and Light Therapy for DepressionCompletedNCT03405493Not applicable
- To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDDCompletedNCT03404466Phase 1/2
- Movement for Depression - An RCT Assessing the Effects of Physical Activity Promotion for People With MDDStatus unknownNCT03403881Not applicable
- Yoga for Young Women With DepressionStatus unknownNCT03388177Not applicable
- A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive DisorderCompletedNCT03374475Phase 1
- Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot TrialCompletedNCT03367533Phase 1
- Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®CompletedNCT03357796Phase 1
- Mechanisms of Mindfulness-Based Cognitive Therapy in the Treatment of Recurrent Major Depressive DisorderCompletedNCT03353493Not applicable
- DBS of the Habenula for Treatment- Resistant Major DepressionTerminatedNCT03347487Not applicable
- Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and DepressionStatus unknownNCT03329287Not applicable
- Evolution of Dark Ideas When Introducing or Switching an AntidepressantTerminatedNCT03327974Not applicable
- Identifying the Neural Basis of Capability for SuicideSuspendedNCT03327129
- Sleep To Reduce Incident Depression EffectivelyCompletedNCT03322774Not applicable
- Investigation of Seasonal Variations of Brain Structure and Connectivity in SADCompletedNCT03313674Not applicable
- Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)CompletedNCT03310281Not applicable
- Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain InjuryCompletedNCT03307070Not applicable
- Trial of Surf and Hike Therapy for Major Depressive DisorderCompletedNCT03302611Not applicable
- Fish Oil as Adjunct Treatment for Major Depressive DisorderStatus unknownNCT03295708Not applicable
- Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive EpisodesCompletedNCT03289923Not applicable
- Stepped Care AiTBS 2 Depression Study (Ghent)CompletedNCT03288675Not applicable
- Effects of Schema Therapy vs. Cognitive Behavioral Therapy vs. Individual Supportive TherapyCompletedNCT03287362Not applicable
- The Effects of tDCS on Depressive Symptoms,Neurocognitive Function and HRV in Unipolar Depression and Bipolar DepressionCompletedNCT03287037Not applicable
- Fecal Microbiota Transplantation in DepressionTerminatedNCT03281044Phase 2
- Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression.CompletedNCT03265808Phase 1/2
- Clinical Effect of dTMS in Major Depressive DisorderCompletedNCT03265340Not applicable
- MRS and Medication Response: A Pilot StudyTerminatedNCT03254342
- Remotely Programmed Deep Brain Stimulation of the Bilateral Habenula for Treatment- Resistant Major Depression: An Open Label Pilot TrialTerminatedNCT03254017Not applicable
- Patient Management of Depression Through Technology: a Study of Digitally Enabled EngagementCompletedNCT03242213Not applicable
- Lactobacillus Plantarum PS128 in Patients With Major Depressive Disorder and High Level of InflammationStatus unknownNCT03237078Not applicable
- Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression DisorderStatus unknownNCT03230682
- Pharmacogenomic Testing in Major Depressive DisorderTerminatedNCT03228953Not applicable
- Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive DisorderTerminatedNCT03222752Not applicable
- Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological CharacteristicsStatus unknownNCT03219008Phase 4
- Neurobehavioral Mechanisms of Emotion Regulation in Depression Across the Adult LifespanCompletedNCT03207503
- Testing the Neuroscience of Guided Learning in DepressionCompletedNCT03203954Not applicable
- Creatine for Treatment of Depression Associated With Type 2 DiabetesWithdrawnNCT03202095Phase 4
- Impact of an Eight Week Exercise Intervention in Treating Major Depressive DisorderStatus unknownNCT03191994Not applicable
- Cognitive Dysfunction in MDD PatientsStatus unknownNCT03187093Phase 4
- Comparison of Anyu Peibo With Placebo in Treatment of MDD，ⅡbCompletedNCT03183505Phase 2
- Dialogue to Empower Traditional and Faith Healers to Deliver mhGAP-IG Adapted Psychosocial Interventions in KenyaCompletedNCT03165513Not applicable
- Laughter Yoga Intervention for People With Major Depressive DisorderCompletedNCT03163940Not applicable
- Improving Access to the Treatment of Anxiety and Depression Among Young AdultsCompletedNCT03156556Not applicable
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy SubjectsCompletedNCT03155503Phase 1
- The Modular Protocol for Mental Health (MPMH)CompletedNCT03143634Phase 1/2
- Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation?CompletedNCT03143075Not applicable
- Rapid Antidepressant Effects of ATP and PhosphocreatineStatus unknownNCT03138681Phase 2
- Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDDCompletedNCT03131050Phase 4
- Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety DisordersStatus unknownNCT03122158Phase 4
- Feasibility of a Technology-Based Treatment Support SystemTerminatedNCT03121937Not applicable
- Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks TrialCompletedNCT03121573Not applicable
- McLean and Genomind Prospective StudyCompletedNCT03113890Not applicable
- Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of AgeCompletedNCT03108625Phase 3
- Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDDTerminatedNCT03101540Early Phase 1
- Open Trial Determining Antidepressant Effects of Omega-3 Supplementation During PregnancyTerminatedNCT03101527Early Phase 1
- Multidomain Intervention for Older Adults With Major Depressive DisorderCompletedNCT03095820Not applicable
- Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) StudyStatus unknownNCT03088657
- Emotional Brain Networks & Cognitive Functioning in Depression and AnxietyStatus unknownNCT03084042
- AV-101 as Adjunct Antidepressant Therapy in Patients With Major DepressionCompletedNCT03078322Phase 2
- Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular DiseasesCompletedNCT03072823Not applicable
- Neurobiology of Treatment Responses in MDDWithdrawnNCT03068247Phase 3
- The Gut Microbiota of Bipolar and DepressionStatus unknownNCT03062332
- Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in DepressionCompletedNCT03062150Not applicable
- Assessment of Hedonic and Motivational States in Major Depression ( MOODDIS)WithdrawnNCT03060967Not applicable
- Open Label Ketamine Treatment for Major Depressive Disorder in VeteransCompletedNCT03053830Phase 2
- Endogenous Opioid Modulation by KetamineWithdrawnNCT03051945Phase 3
- Examining the Effects of Reduced Environmental Stimulation on AnxietyCompletedNCT03051074Not applicable
- Exploring Effects of Electroconvulsive Therapy on the Human Brain in Depression - The Danish ECT/MRI StudyCompletedNCT03040388
- Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed PatientsStatus unknownNCT03039387Not applicable
- Sex, Hormones and Gamma-Aminobutyric Acid (GABA) in Stress Induced Anhedonia in DepressionCompletedNCT03031665
- Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant DepressionCompletedNCT03027362Not applicable
- Neuroimaging Studies of Reward Processing in DepressionCompletedNCT03026036
- Promote Access to Stop Suicide: Comparison of Follow up Services for Youth at Risk for SuicideCompletedNCT03016572Not applicable
- Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)CompletedNCT03014544
- Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)Status unknownNCT03012724Not applicable
- The Experience of Older Adults Facing Depression for the First Time in Old AgeStatus unknownNCT03009448
- A 7-year Assessment on Subject Understanding of ZYBAN/ WELLBUTRIN Associated RisksCompletedNCT03001440
- Long-Term Follow Up StudyCompletedNCT02998762
- Feasibility of a Behavioral Activation TrialCompletedNCT02992158Not applicable
- Pilot BA Study of New LY03005 vs PristiqCompletedNCT02988024Phase 1
- Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid NeuroimagingStatus unknownNCT02983838
- Molecular Imaging of Brain Inflammation in Depressive DisordersCompletedNCT02983318
- fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBITerminatedNCT02980484Phase 2
- N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive DisordersStatus unknownNCT02972398Not applicable
- Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life DepressionActive, not recruitingNCT02959502Not applicable
- A Closed-loop Assessment and Treatment Platform for Unipolar Depression and AnxietyCompletedNCT02948036Not applicable
- Gaze Contingent Feedback in Major Depressive Disorder (MDD)CompletedNCT02945735Not applicable
- Relapse Predicting Model for First Episode DepressionStatus unknownNCT02942251Not applicable
- Neurobiological Effects of Light on MDDTerminatedNCT02940769Not applicable
- Can the Memory Support Intervention Improve Depression Outcome Following Cognitive Therapy?CompletedNCT02938559Not applicable
- Burst Suppression Anesthesia for Treatment of Severe DepressionCompletedNCT02935647Phase 1
- Wellness Monitoring for Major Depressive DisorderCompletedNCT02934334